Movement Priming for Stroke Recovery
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to explore how different movement exercises can improve leg functions and brain adaptability in people who have had a stroke. Participants will engage in various movement-based priming sessions, including exercises focused on upper limb movement (Upper limb-based movement priming or UL-priming) and listening to rhythmic sounds (Sham priming), to determine which is most effective. It targets individuals who experienced a stroke over six months ago and have difficulty walking as a result. As an unphased trial, this study offers participants a unique opportunity to contribute to innovative research that could enhance rehabilitation strategies for stroke survivors.
Will I have to stop taking my current medications?
The trial requires that participants do not use anti-spasticity medications and medications that could alter brain activity or increase seizure risk, like antidepressants, antipsychotics, anxiolytics, and anticonvulsants.
What prior data suggests that this movement-based priming technique is safe for stroke recovery?
Research shows that upper limb-based movement priming (UL-priming) is generally safe and well-tolerated by stroke survivors. Studies have examined its use with other therapies and found no major safety issues. Participants in these studies typically handle the treatment well, with no serious side effects reported.
For lower limb-based movement priming (LL-priming), research also supports its safety. Studies suggest that this type of movement therapy is not only affordable but also safe for many people. It requires no special equipment and has proven practical and acceptable for stroke survivors.
Both UL-priming and LL-priming treatments are gentle and focus on rhythmic movements. So far, studies have shown that these methods are safe and well-tolerated by stroke survivors.12345Why are researchers excited about this trial?
Researchers are excited about the Movement Priming techniques for stroke recovery because they explore innovative ways to enhance rehabilitation. Unlike traditional therapies focusing solely on repetitive exercises or medication, these methods use rhythmic, bilateral movements to stimulate and prime the nervous system, potentially improving motor function. Specifically, the treatments include upper limb-priming, which involves moving major joints like the shoulder and elbow, and lower limb-priming, which focuses on foot movements. This approach could lead to more effective recovery by directly engaging the body's natural movement patterns, offering a fresh angle compared to standard physical therapy.
What evidence suggests that this trial's treatments could be effective for stroke recovery?
Research shows that exercises focusing on arm movements, known as Upper limb-based movement priming (UL-priming), can significantly aid in recovering movement after a stroke. Studies have found that individuals using UL-priming experienced better balance in brain activity related to movement compared to those who did not use it. This suggests that UL-priming might also enhance leg movement by boosting the brain's ability to change and adapt. Participants in this trial may receive UL-priming as part of their treatment.
For exercises focusing on leg movements, known as Lower limb-based movement priming (LL-priming), research has found that it increases brain activity related to movement. One study noted a 25% increase in activity on the affected side of the brain after using LL-priming. This suggests LL-priming may also improve movement and recovery in stroke patients. Participants in this trial may receive LL-priming as part of their treatment.15678Who Is on the Research Team?
Sangeetha Madhavan, PT, PhD
Principal Investigator
University of Illinois at Chicago
Are You a Good Fit for This Trial?
This trial is for individuals who have had a single stroke affecting one side of the brain at least 6 months ago and are experiencing walking difficulties. They must be able to perform certain arm movements and not be taking specific medications that affect the brain's activity or increase seizure risk. People with severe cognitive impairment, other neurological disorders, uncontrolled medical conditions, or those who can't follow instructions due to language barriers cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Priming Sessions
Participants undergo three priming sessions: UL-priming, sham priming, and LL-priming
Immediate Follow-up
Participants are assessed for changes in muscle strength and corticomotor excitability immediately after each priming session
Short-term Follow-up
Participants are monitored for changes in muscle strength and gait speed at 30 and 60 minutes after priming
Long-term Follow-up
Participants are assessed for changes in muscle strength and corticomotor excitability 24 hours after priming
What Are the Treatments Tested in This Trial?
Interventions
- Lower limb-based movement priming (LL-priming)
- Sham priming
- Stimulation-based priming (Stim priming)
- Upper limb-based movement priming (UL-priming)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Illinois at Chicago
Lead Sponsor